tradipitant (VLY-686) / Vanda 
Welcome,         Profile    Billing    Logout  
 2 Diseases   5 Trials   5 Trials   115 News 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tradipitant (VLY-686) / Vanda
2020-005526-29: A randomized, double-blind, placebo-controlled study to investigate the efficacy of tradipitant in treating inflammatory lung injury and improving clinical outcomes associated with severe COVID-19 infection.

Not yet recruiting
3
300
Europe
tradipitant, VLY-686, Capsule, hard
Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc.
inflammatory lung injury associated with severe COVID-19 infection, inflammatory lung injury associated with severe COVID-19 infection, Diseases [C] - Virus Diseases [C02]
 
 
NCT06138613: Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Recruiting
3
500
US
Tradipitant
Vanda Pharmaceuticals
Motion Sickness
04/25
04/25
NCT05903924: Motion Serifos: a Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness

Completed
3
316
US
Tradipitant, Placebo
Vanda Pharmaceuticals
Motion Sickness
04/24
04/24
VP-VLY-686-3301, NCT04028492: Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

Recruiting
3
201
US
Tradipitant, Placebo, Open Label Tradipitant
Vanda Pharmaceuticals
Idiopathic Gastroparesis, Diabetic Gastroparesis, Gastroparesis
12/24
12/24
Vanda, NCT02672410: Tradipitant in Treatment-Resistant Pruritus Associated With Atopic Dermatitis

Not yet recruiting
2
7
US
Tradipitant, Placebo
Sadick Research Group
Atopic Dermatitis
12/17
 
NCT05653310: Tradipitant for Functional Dyspepsia

Enrolling by invitation
2
60
US
Tradipitant, Placebo
Xiao Jing (Iris) Wang, Mayo Clinic
Functional Dyspepsia
12/25
12/25
NCT04849559: Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers

Completed
1/2
27
US
Tradipitant, Placebo
Vanda Pharmaceuticals, Mayo Clinic
Healthy Volunteer
09/21
09/21
NCT04474990: Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis

Available
N/A
US
Tradipitant
Vanda Pharmaceuticals
Gastroparesis, Diabetic Gastroparesis
 
 

Download Options